Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Amphastar Pharmaceuticals, Inc. (AMPH) had Weighted-Average Shares Outstanding (Diluted) of 49.89M for the most recently reported fiscal quarter, ending 2025-03-31.
Income Statement Financials | |
$170.53M |
|
$25.29M |
|
$85.28M |
|
$85.25M |
|
$133.24M |
|
$37.29M |
|
$-6.43M |
|
$30.86M |
|
$30.86M |
|
$25.29M |
|
$25.29M |
|
$25.29M |
|
$25.29M |
|
$37.29M |
|
$51.66M |
|
47.64M |
|
Weighted-Average Shares Outstanding (Diluted) |
49.89M |
$0.53 |
|
$0.51 |
|
Balance Sheet Financials | |
$587.96M |
|
$307.60M |
|
$1.04B |
|
$1.63B |
|
$199.05M |
|
$603.86M |
|
$675.94M |
|
$874.99M |
|
$751.28M |
|
$166.75M |
|
$751.28M |
|
47.67M |
|
Cash Flow Statement Financials | |
$35.08M |
|
$10.48M |
|
$-14.50M |
|
$151.84M |
|
$183.02M |
|
$31.17M |
|
$8.39M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
2.95 |
|
-- |
|
-- |
|
0.45 |
|
0.80 |
|
49.99% |
|
21.87% |
|
21.87% |
|
-- |
|
18.10% |
|
14.83% |
|
$24.38M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.46 |
|
1.17 |
|
76.73 |
|
3.37% |
|
15.16% |
|
1.55% |
|
1.87% |
|
$15.76 |
|
$0.49 |
|
$0.70 |